ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. (Q48530200)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 May 2006

Language	Label	Description	Also known as
English	ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures.	scientific article published on 18 May 2006

Statements

scholarly article

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. (English)

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Young Hae Chong

1

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Yoo Jeong Shin

2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Eun Ok Lee

3

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Rakez Kayed

4

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Charles G Glabe

5

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Andrea J Tenner

6

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

language of work or name

0 references

publication date

18 May 2006

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Journal of Biological Chemistry

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

281

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

29

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

20315-20325

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Pathways towards and away from Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Deciphering the molecular basis of memory failure in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Femtomole Immunodetection of Synthetic and Endogenous Amyloid-β Oligomers and Its Application to Alzheimer's Disease Drug Candidate Screening

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Tau is essential to beta -amyloid-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Stability of the preclinical episodic memory deficit in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Neuronal activity regulates gabaa receptor subunit expression in organotypic hippocampal slice cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Identification of the critical features of a small peptide inhibitor of JNK activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by beta-amyloid.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Mechanisms of neurodegenerative disorders: Part 2: control of cell death.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Soluble oligomeric Abeta disrupts the protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

A role for ERK MAP kinase in physiologic temporal integration in hippocampal area CA1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer's disease model.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601016200

21 January 2018

Identifiers

10.1074/JBC.M601016200

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/16714296

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48530200&oldid=1588020412"